Biogen And Eisai Say Alzheimer’s Drug A Success, Encouraging Phase II Results in Alzheimer’s Disease

2020-08-17T20:53:26-07:00Industry News|

A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are [...]